Table 2.

Univariate Fine-Gray models of women diagnosed with grade 3 breast cancer in NZ

Age	SHR	Robust SE	Z	p	CI
41–50	0.578	0.170	−1.86	0.063	0.324	1.030
51–60	0.944	0.253	−0.22	0.830	0.558	1.597
61–70	0.728	0.213	−1.08	0.278	0.411	1.291
71–80	1.738	0.495	1.94	0.053	0.994	3.038
> 80	2.253	0.689	2.66	0.008	1.237	4.104
Ethnicity
Maori	1.445	0.584	0.91	0.363	0.654	3.191
NZ European	1.695	0.558	1.60	0.109	0.889	3.232
Asian	1.287	0.833	0.39	0.697	0.362	4.574
Pacific Islander	1.440	0.681	0.77	0.440	0.570	3.639
Histotype
Ductal	1.347	0.684	0.59	0.557	0.498	3.645
Mixed	0.779	0.525	−0.37	0.711	0.208	2.917
HR Status
ER−/PR+	1.200	1.181	0.19	0.853	0.175	8.257
ER+/PR-	3.555	0.774	5.82	0.000	2.320	5.447
ER−/PR-	2.672	0.534	4.92	0.000	1.807	3.952
Stage
II	1.829	1.081	1.02	0.307	0.574	5.828
III	1.994	1.409	0.98	0.329	0.499	7.964
IV	79.415	40.194	8.64	0.000	29.450	214.148
X	6.189	6.949	1.62	0.104	0.685	55.886
Subtype
Luminal B	3.354	1.094	3.71	0.000	1.770	6.358
Her2 Enriched	1.659	0.519	1.62	0.105	0.899	3.062
Triple Negative	3.013	0.715	4.65	0.000	1.892	4.799